These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 26840044)
1. Somatic mutations rather than viral infection classify focal cortical dysplasia type II as mTORopathy. Blümcke I; Sarnat HB Curr Opin Neurol; 2016 Jun; 29(3):388-95. PubMed ID: 26840044 [TBL] [Abstract][Full Text] [Related]
2. Somatic Mutations in TSC1 and TSC2 Cause Focal Cortical Dysplasia. Lim JS; Gopalappa R; Kim SH; Ramakrishna S; Lee M; Kim WI; Kim J; Park SM; Lee J; Oh JH; Kim HD; Park CH; Lee JS; Kim S; Kim DS; Han JM; Kang HC; Kim HH; Lee JH Am J Hum Genet; 2017 Mar; 100(3):454-472. PubMed ID: 28215400 [TBL] [Abstract][Full Text] [Related]
3. Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy. Lim JS; Kim WI; Kang HC; Kim SH; Park AH; Park EK; Cho YW; Kim S; Kim HM; Kim JA; Kim J; Rhee H; Kang SG; Kim HD; Kim D; Kim DS; Lee JH Nat Med; 2015 Apr; 21(4):395-400. PubMed ID: 25799227 [TBL] [Abstract][Full Text] [Related]
4. Cortical Dysplasia and the mTOR Pathway: How the Study of Human Brain Tissue Has Led to Insights into Epileptogenesis. Lee WS; Baldassari S; Stephenson SEM; Lockhart PJ; Baulac S; Leventer RJ Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163267 [TBL] [Abstract][Full Text] [Related]
7. Somatic Mutations in the MTOR gene cause focal cortical dysplasia type IIb. Nakashima M; Saitsu H; Takei N; Tohyama J; Kato M; Kitaura H; Shiina M; Shirozu H; Masuda H; Watanabe K; Ohba C; Tsurusaki Y; Miyake N; Zheng Y; Sato T; Takebayashi H; Ogata K; Kameyama S; Kakita A; Matsumoto N Ann Neurol; 2015 Sep; 78(3):375-86. PubMed ID: 26018084 [TBL] [Abstract][Full Text] [Related]
8. Balloon cells promote immune system activation in focal cortical dysplasia type 2b. Zimmer TS; Broekaart DWM; Luinenburg M; Mijnsbergen C; Anink JJ; Sim NS; Michailidou I; Jansen FE; van Rijen PC; Lee JH; François L; van Eyll J; Dedeurwaerdere S; van Vliet EA; Mühlebner A; Mills JD; Aronica E Neuropathol Appl Neurobiol; 2021 Oct; 47(6):826-839. PubMed ID: 34003514 [TBL] [Abstract][Full Text] [Related]
9. Review: Mechanistic target of rapamycin (mTOR) pathway, focal cortical dysplasia and epilepsy. Marsan E; Baulac S Neuropathol Appl Neurobiol; 2018 Feb; 44(1):6-17. PubMed ID: 29359340 [TBL] [Abstract][Full Text] [Related]
10. Somatic variants in new candidate genes identified in focal cortical dysplasia type II. Zhang Z; Gao K; Liu Q; Zhou J; Li X; Lang N; Liu M; Wang T; Zhang J; Wang H; Dong Y; Ji T; Wang S; Liu X; Jiang Y; Cai L; Wu Y Epilepsia; 2020 Apr; 61(4):667-678. PubMed ID: 32216069 [TBL] [Abstract][Full Text] [Related]
11. Somatic double-hit in MTOR and RPS6 in hemimegalencephaly with intractable epilepsy. Pelorosso C; Watrin F; Conti V; Buhler E; Gelot A; Yang X; Mei D; McEvoy-Venneri J; Manent JB; Cetica V; Ball LL; Buccoliero AM; Vinck A; Barba C; Gleeson JG; Guerrini R; Represa A Hum Mol Genet; 2019 Nov; 28(22):3755-3765. PubMed ID: 31411685 [TBL] [Abstract][Full Text] [Related]
12. Brain somatic mutations in MTOR leading to focal cortical dysplasia. Lim JS; Lee JH BMB Rep; 2016 Feb; 49(2):71-2. PubMed ID: 26779999 [TBL] [Abstract][Full Text] [Related]
13. Familial cortical dysplasia caused by mutation in the mammalian target of rapamycin regulator NPRL3. Sim JC; Scerri T; Fanjul-Fernández M; Riseley JR; Gillies G; Pope K; van Roozendaal H; Heng JI; Mandelstam SA; McGillivray G; MacGregor D; Kannan L; Maixner W; Harvey AS; Amor DJ; Delatycki MB; Crino PB; Bahlo M; Lockhart PJ; Leventer RJ Ann Neurol; 2016 Jan; 79(1):132-7. PubMed ID: 26285051 [TBL] [Abstract][Full Text] [Related]
14. mTOR pathway: Insights into an established pathway for brain mosaicism in epilepsy. Gerasimenko A; Baldassari S; Baulac S Neurobiol Dis; 2023 Jun; 182():106144. PubMed ID: 37149062 [TBL] [Abstract][Full Text] [Related]
15. The role of somatic mutational events in the pathogenesis of epilepsy. Iffland PH; Crino PB Curr Opin Neurol; 2019 Apr; 32(2):191-197. PubMed ID: 30762606 [TBL] [Abstract][Full Text] [Related]
16. Focal cortical dysplasia pathology: diagnostic difficulty, classification, and utility for pathogenesis. Kapar O; Gurkan ZM; Dolgun M; Sencer A; Gürses C; Bilgic B Neurosurg Focus; 2022 Oct; 53(4):E6. PubMed ID: 36183176 [TBL] [Abstract][Full Text] [Related]
17. SLC35A2 somatic variants in drug resistant epilepsy: FCD and MOGHE. Elziny S; Crino PB; Winawer M Neurobiol Dis; 2023 Oct; 187():106299. PubMed ID: 37739137 [TBL] [Abstract][Full Text] [Related]
18. Notch signaling in human iPS-derived neuronal progenitor lines from Focal Cortical Dysplasia patients. Majolo F; Marinowic DR; Machado DC; Da Costa JC Int J Dev Neurosci; 2018 Oct; 69():112-118. PubMed ID: 30048676 [TBL] [Abstract][Full Text] [Related]
19. A brain somatic RHEB doublet mutation causes focal cortical dysplasia type II. Zhao S; Li Z; Zhang M; Zhang L; Zheng H; Ning J; Wang Y; Wang F; Zhang X; Gan H; Wang Y; Zhang X; Luo H; Bu G; Xu H; Yao Y; Zhang YW Exp Mol Med; 2019 Jul; 51(7):1-11. PubMed ID: 31337748 [TBL] [Abstract][Full Text] [Related]
20. Somatic mutations involving TSC 1 and TSC2 genes in two children with focal cortical dysplasia. Jha R; Kurup A; Kovilapu UB; Ranjan R; Sondhi V Brain Dev; 2022 Feb; 44(2):166-172. PubMed ID: 34756499 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]